FDA Drug recall D-580-2013
Lorazepam, 0.5 mg tablets, 100 count, RX only, Distributed by Major Pharmaceuticals, Livonia, MI. NDC 0904-6007-60
- FDA Drug
- Class III
- terminated
- Published 2013-06-12
On 2013-06-12 the FDA classified a Class III recall of Lorazepam, 0.5 mg tablets, 100 count, RX only, Distributed by Major Pharmaceuticals, Livonia, MI. NDC 0904-6007-60 by Legacy Pharmaceutical Packaging, citing labeling: Incorrect or Missing Lot and/or Exp Date: Lorazepam Lot # L-04009.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-580-2013 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2013-03-27 |
| Published | 2013-06-12 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Legacy Pharmaceutical Packaging |
| Distribution | IN |
Product
Lorazepam, 0.5 mg tablets, 100 count, RX only, Distributed by Major Pharmaceuticals, Livonia, MI. NDC 0904-6007-60
Reason
Labeling: Incorrect or Missing Lot and/or Exp Date: Lorazepam Lot # L-04009
Identifiers
| code_info | L-04009 Exp.11/15 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-580-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.